home / stock / zlab / zlab news

ZLAB News and Press, Zai Lab Limited From 02/17/22

Stock Information
Company Name: Zai Lab Limited
Stock Symbol: ZLAB
Market: NASDAQ
Website: zailaboratory.com
Menu
ZLAB ZLAB Quote ZLAB Short ZLAB News ZLAB Articles ZLAB Message Board
Get ZLAB Alerts

News, Short Squeeze, Breakout and More Instantly...
ZLAB - Zai Lab Announces Breakthrough Therapy Designation Granted for Repotrectinib in China

SHANGHAI and SAN FRANCISCO and CAMBRIDGE, Mass., Feb. 17, 2022 (GLOBE NEWSWIRE) -- Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688), a patient-focused, innovative, commercial-stage, global biopharmaceutical company, today announced that the Center for Drug Evaluation (CDE) of the National Medical...
ZLAB - Zai Lab to Announce Full-Year Financial Results and Corporate Updates on March 1, 2022

SHANGHAI and SAN FRANCISCO and CAMBRIDGE, Mass., Feb. 15, 2022 (GLOBE NEWSWIRE) -- Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688), a patient-focused, innovative, commercial-stage, global biopharmaceutical company, today announced that it will report financial results and corporate updates for t...

ZLAB - Chinese biotechs lower after WuXi Biologics added to U.S. 'unverified' list

U.S.-listed Chinese biotech companies are trading lower after the U.S. commerce department added life-sciences company, WuXi Biologics (OTCPK:WXXWY -13.5%) (OTCPK:WXIBF -22.6%), to its “unverified” list for exporters. Notable decliners include I-Mab (IMAB -5.7%) and BeiGene (BGN...

ZLAB - Zai Lab Announces Upcoming Presentation at February Investor Conference

SHANGHAI and SAN FRANCISCO and CAMBRIDGE, Mass., Feb. 07, 2022 (GLOBE NEWSWIRE) -- Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688), a patient-focused, innovative, commercial-stage, global biopharmaceutical company, today announced that management from Zai Lab will be presenting at the following ...
ZLAB - ClearBridge Global Growth Strategy Portfolio Manager Commentary Q4 2021

ClearBridge is a leading global asset manager committed to active management. Research-based stock selection guides our investment approach, with our strategies reflecting the highest-conviction ideas of our portfolio managers. Strategy outperformance was driven by our U.S. exposure, ...

ZLAB - ClearBridge International Growth ACWI Ex-US Strategy Portfolio Manager Commentary Q4 2021

ClearBridge is a leading global asset manager committed to active management. Research-based stock selection guides our investment approach, with our strategies reflecting the highest-conviction ideas of our portfolio managers. Strategy outperformance was driven by diversified contrib...

ZLAB - Promising Developments in Breast Cancer Treatments Ahead in 2022

FN Media Group Presents USA News Group News Commentary Vancouver, BC – January 12, 2022 – USA News Group –  So far in 2022, there have already been some impressive developments in the battle against breast cancer, which over the last decade has ...
ZLAB - Biotech Sector Answering Calls for New Breast Cancer Treatment Developments in 2022

VANCOUVER – USA News Group – So far in 2022, there have already been some impressive developments in the battle against breast cancer, which over the last decade has been the leading killer of female cancer patients, according to a decade long analysis . In just the fi...

ZLAB - Zai Lab Announces First Patient Treated in Greater China in PANOVA-3 Phase 3 Pivotal Trial of Tumor Treating Fields in Pancreatic Cancer

SHANGHAI, SAN FRANCISCO, and CAMBRIDGE, Mass., Jan. 12, 2022 (GLOBE NEWSWIRE) -- Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688), a patient-focused, innovative, commercial-stage, global biopharmaceutical company, today announced treatment of the first patient in Greater China in the PANOVA-3 tri...

ZLAB - Zai Lab Announces NDA Acceptance of Margetuximab for Patients with Pretreated Metastatic HER2-Positive Breast Cancer in China by the NMPA

SHANGHAI and SAN FRANCISCO and CAMBRIDGE, Mass., Jan. 06, 2022 (GLOBE NEWSWIRE) -- Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688), a patient-focused, innovative, commercial-stage, global biopharmaceutical company, today announced that the China National Medical Products Administration (NMPA) ha...
Previous 10 Next 10